244 related articles for article (PubMed ID: 22529951)
21. Association between XRCC1 gene polymorphisms and risk of glioma development: a meta-analysis.
Sun JY; Zhang CY; Zhang ZJ; Dong YF; Zhang AL; Wang ZW; Mei XL
Asian Pac J Cancer Prev; 2012; 13(9):4783-8. PubMed ID: 23167420
[TBL] [Abstract][Full Text] [Related]
22. XRCC1 gene polymorphisms and the risk of differentiated thyroid carcinoma (DTC): a meta-analysis of case-control studies.
Bao Y; Jiang L; Zhou JY; Zou JJ; Zheng JY; Chen XF; Liu ZM; Shi YQ
PLoS One; 2013; 8(5):e64851. PubMed ID: 23717668
[TBL] [Abstract][Full Text] [Related]
23. Associations between XRCC1 Gene Polymorphisms and Coronary Artery Disease: A Meta-Analysis.
Ma WQ; Han XQ; Wang X; Wang Y; Zhu Y; Liu NF
PLoS One; 2016; 11(11):e0166961. PubMed ID: 27870881
[TBL] [Abstract][Full Text] [Related]
24. The XRCC1 Arg194Trp and Arg280His polymorphisms in head and neck cancer susceptibility: a meta-analysis.
Zhou X; Gu L; Zeng Y; Wei L; Ying M; Wang N; Su C; Wang Y; Liu C
Tumour Biol; 2014 Nov; 35(11):10665-76. PubMed ID: 25062722
[TBL] [Abstract][Full Text] [Related]
25. Correlation between X-ray cross-complementing group 1 polymorphisms and the onset risk of glioma: A meta-analysis.
Gu X; Sun H; Chang L; Sun R; Yang H; Zhang X; Cong X
Neural Regen Res; 2013 Sep; 8(26):2468-77. PubMed ID: 25206557
[TBL] [Abstract][Full Text] [Related]
26. Association between XRCC1 polymorphisms and the risk of cervical cancer: a meta-analysis based on 4895 subjects.
Zeng X; Zhang Y; Yue T; Zhang T; Wang J; Xue Y; An R
Oncotarget; 2017 Jan; 8(2):2249-2260. PubMed ID: 27903984
[TBL] [Abstract][Full Text] [Related]
27. A Meta-Analysis for Association of XRCC1, XRCC2 and XRCC3 Polymorphisms with Susceptibility to Thyroid Cancer.
Mandegari M; Dastgheib SA; Asadian F; Shaker SH; Tabatabaie SM; Kargar S; Sadeghizadeh-Yazdi J; Neamatzadeh H
Asian Pac J Cancer Prev; 2021 Jul; 22(7):2221-2236. PubMed ID: 34319046
[TBL] [Abstract][Full Text] [Related]
28. Associations between XRCC1 Arg399Gln, Arg194Trp, and Arg280His polymorphisms and risk of differentiated thyroid carcinoma: a meta-analysis.
Du Y; Han LY; Li DD; Liu H; Gao YH; Sun DJ
Asian Pac J Cancer Prev; 2013; 14(9):5483-7. PubMed ID: 24175846
[TBL] [Abstract][Full Text] [Related]
29. The polymorphism of XRCC1 and coronary artery disease risk: a meta-analysis.
Guo SJ; Zhou YT; Liu WY; Zuo QN; Li XH
Eur Rev Med Pharmacol Sci; 2017 Apr; 21(7):1559-1567. PubMed ID: 28429350
[TBL] [Abstract][Full Text] [Related]
30. Association between XRCC1 and XRCC3 polymorphisms with lung cancer risk: a meta-analysis from case-control studies.
Huang G; Cai S; Wang W; Zhang Q; Liu A
PLoS One; 2013; 8(8):e68457. PubMed ID: 23990873
[TBL] [Abstract][Full Text] [Related]
31. XRCC1 gene polymorphisms and glioma risk in Chinese population: a meta-analysis.
He LW; Shi R; Jiang L; Zeng Y; Ma WL; Zhou JY
PLoS One; 2014; 9(11):e111981. PubMed ID: 25375625
[TBL] [Abstract][Full Text] [Related]
32. Genetic polymorphisms in the DNA repair gene, XRCC1 associate with non-Hodgkin lymphoma susceptibility: A systematic review and meta-analysis.
Li Y; Bai O; Cui J; Li W
Eur J Med Genet; 2016 Feb; 59(2):91-103. PubMed ID: 26723520
[TBL] [Abstract][Full Text] [Related]
33. No association between XRCC1 genetic polymorphisms and differentiated thyroid carcinoma risk: a meta-analysis.
Li C; Xiang X; Zhou Y
Mol Biol Rep; 2014 Nov; 41(11):7613-21. PubMed ID: 25086624
[TBL] [Abstract][Full Text] [Related]
34. XRCC1 genetic polymorphism Arg339Gln, Arg194Trp, Arg280His and gastric cancer risk: an evidence based decision.
Zhao DY; Cheng L; Yu J; Shen H
Cancer Biomark; 2014; 14(6):449-56. PubMed ID: 25335737
[TBL] [Abstract][Full Text] [Related]
35. DNA repair gene XRCC1 polymorphisms and head and neck cancer risk: an updated meta-analysis including 16344 subjects.
Lou Y; Peng WJ; Cao DS; Xie J; Li HH; Jiang ZX
PLoS One; 2013; 8(9):e74059. PubMed ID: 24086310
[TBL] [Abstract][Full Text] [Related]
36. Polymorphisms of DNA repair gene XRCC1 and hepatocellular carcinoma risk among East Asians: a meta-analysis.
Li J; Li Z; Feng L; Guo W; Zhang S
Tumour Biol; 2013 Feb; 34(1):261-9. PubMed ID: 23055199
[TBL] [Abstract][Full Text] [Related]
37. Meta-analysis of associations between XRCC1 gene polymorphisms and susceptibility to systemic lupus erythematosus and rheumatoid arthritis.
Zhang MY; Yang XK; Lv TT; Wu J; Xu SZ; Wang JB; Pan HF; Ye DQ
Int J Rheum Dis; 2018 Jan; 21(1):179-185. PubMed ID: 28198159
[TBL] [Abstract][Full Text] [Related]
38. Association of X-ray repair cross complementing group 1 Arg399Gln polymorphisms with the risk of squamous cell carcinoma of the head and neck: evidence from an updated meta-analysis.
Wang Y; Chu X; Meng X; Zou F
PLoS One; 2013; 8(10):e77898. PubMed ID: 24205020
[TBL] [Abstract][Full Text] [Related]
39. Association of XRCC1 polymorphisms with thyroid cancer risk.
Wang C; Ai Z
Tumour Biol; 2014 May; 35(5):4791-7. PubMed ID: 24477575
[TBL] [Abstract][Full Text] [Related]
40. X-ray repair cross-complementing group 1 (XRCC1) genetic polymorphisms and gastric cancer risk: A HuGE review and meta-analysis.
Xue H; Ni P; Lin B; Xu H; Huang G
Am J Epidemiol; 2011 Feb; 173(4):363-75. PubMed ID: 21216841
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]